SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | -33.3% | 58,386 | 0.0% | 0.00% | – |
| Q4 2015 | $21,000 | -79.4% | 58,386 | 0.0% | 0.00% | – |
| Q3 2015 | $102,000 | -21.5% | 58,386 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $130,000 | +39.8% | 58,386 | +21.6% | 0.00% | – |
| Q1 2015 | $93,000 | -30.1% | 48,005 | -4.7% | 0.00% | -100.0% |
| Q4 2014 | $133,000 | -10.7% | 50,368 | +1.5% | 0.00% | 0.0% |
| Q3 2014 | $149,000 | -17.7% | 49,620 | +12.3% | 0.00% | 0.0% |
| Q2 2014 | $181,000 | +9.7% | 44,193 | +15.1% | 0.00% | 0.0% |
| Q1 2014 | $165,000 | -17.9% | 38,383 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $201,000 | -1.0% | 38,383 | +19.3% | 0.00% | 0.0% |
| Q3 2013 | $203,000 | +32.7% | 32,182 | +4.8% | 0.00% | 0.0% |
| Q2 2013 | $153,000 | – | 30,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |